(Q44834877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

C A Perez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J N Fields

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

P M Fracasso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

G Philpott

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

R L Soares

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

M E Taylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

M A Lockett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

C Rush

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

1 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

466-476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory carcinoma of the breast: the case for conservatism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory carcinoma of the breast: treatment results on 107 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Role of surgery in the treatment of inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Mastectomy in the management of patients with inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Secondary inflammatory breast cancer: treatment options

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Primary radiation therapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Maximum utilization of the life table method in analyzing survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory cancer of the breast: Analysis of 114 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory breast carcinoma treated by radical radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Results of radical radiotherapy for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Management of inflammatory carcinoma of breast with combined modality approach - an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Management of inflammatory carcinoma of the breast. A combined modality approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Multimodal treatment for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Combined therapy for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. A phase II study of 25 cases with a median follow-up of 35 months

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Surgery as part of a combined modality approach for inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

The effect of systemic therapy on local-regional control in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Locally advanced breast cancer treated with neutron beams: long-term follow-up in 28 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Prognostic factors in locally advanced breast cancer (T3, T4) with special reference to tumor cell DNA content

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741336

7 January 2021

Identifiers

DOI

10.1002/CNCR.2820741336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004622%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference